Saturday , 8 August 2020

Case Studies Showing Comparison between CIS Countries and EU Regulatory Frame Considering the Development of Russian Regulatory Legislation and Marketing Authorization of Herbal Medicinal Products

B. Ranganayakulu*, D. Venkata Prasad1, Dr. S Mohammed Yusuf2, Dr.A.Srikanth3
*2Associate Professor, Srinivasa Institute of Pharmaceutical Sciences, Proddatur, A.P, India
1Srinivasa institute of Pharmaceutical Sciences, Proddatur, A.P., India
3Assistant Professor, Vasavi Institute of Pharmaceutical Sciences, Kadapa, A.P., India

A B S T R A C T
A European study on current regulatory legislation in the CIS Countries & Marketing authorization of herbal medicinal products in CIS countries was done for comparing the current regulations of both in CIS countries along with EU regulations. In this study includes not only marketing authorization but also the basic principles of the clinical trials required for registration procedures as well as some regulatory aspects of successful market access and post-marketing maintenance activities.
Keywords: Herbal medicinal products, Marketing Authorization, EU & CIS Regulatory Legislation.

Scroll To Top